Last reviewed · How we verify
NCT04054310
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NA trial testing Liver Multi Scan in NASH - Nonalcoholic Steatohepatitis in 225 participants. Currently enrolling.
1 February 2026
Quick facts
| Lead sponsor | Perspectum |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 225 |
| Start date | 5 August 2020 |
| Primary completion | 1 February 2026 |
| Estimated completion | 1 February 2026 |
| Sites | 7 locations across United States |
Drugs / interventions tested
- Liver Multi Scan
Conditions studied
- NASH - Nonalcoholic Steatohepatitis — all drugs for NASH - Nonalcoholic Steatohepatitis →
Sponsor
Perspectum
Who can join
Adults 18 to 75, any sex, with NASH - Nonalcoholic Steatohepatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04054310
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for NASH - Nonalcoholic Steatohepatitis
Currently open trials in the same condition.
- NCT05499949 — The Franciscus Obesity NASH Study · active not recruiting
- NCT05023044 — Nonalcoholic Fatty Liver Disease in HIV Database · active not recruiting
- NCT04232566 — Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity · recruiting
- NCT05165446 — Novel MRE Technique to Assess a Risk Factor for Liver Cancer · active not recruiting
- NCT04697810 — Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) · Phase 2 · recruiting
Other Perspectum trials
Trials by the same sponsor.
- NCT07098650 — Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System · recruiting
- NCT04974710 — Developing an US-MRI Biomarker Fusion Model for Endometriosis · completed
- NCT05326191 — First-trimester Placental Ultrasound Study · completed
- NCT05000242 — West Hertfordshire Inflammatory Bowel Disease Technology Study · active not recruiting
- NCT05110248 — Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04054310 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Perspectum
- Last refreshed: 1 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04054310.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing